Term
| used in all patients for risk modification; decreases morbidity and mortality 25-30% |
|
Definition
| Aspirin 81-325 mg daily (if CI use Plavix 75 mg daily) |
|
|
Term
| Used to manage hypertension (risk factor modification) |
|
Definition
| ACE inhibitors and Beta Blockers |
|
|
Term
| converted to nitrous oxide --> Vasodilation of the coronary arteries (help increase oxygen supply) |
|
Definition
|
|
Term
| blocking beta1 activity --> decrease HR and contractility, which helps to decrease oxygen demand |
|
Definition
| Metoprolol (B1), Propranolol (B1, B2) |
|
|
Term
|
Definition
| beta 1 selectivity (metoprolol, atenolol) |
|
|
Term
| contraindicated in patients with HR < 50 bpm, CHF, heart block or acute bronchospasm |
|
Definition
|
|
Term
| preferred for angina with variable thresholds |
|
Definition
|
|
Term
| works on peripheral vascular smooth muscle --> systemic vasodilationo; preferred in patients with conduction issue or EF < 35% |
|
Definition
|
|
Term
| works on both systemic vasculature and myocardial smooth muscle |
|
Definition
| diltiazem and verapamil (non-DHPs) |
|
|
Term
| 5-10 mg daily; used for chronic stable and variant angina, hypertension; ADRs: HA, flushing, edema, reflex tachycardia, decreased BP |
|
Definition
|
|
Term
| used for chronic stable and variant angina, hypertension, A fib, A flutter, PSVT; ADRS include HA, flushing, decreased HR, decreased BP, CYP 3A4 inhibitor |
|
Definition
|
|
Term
| adjust in hepatic and renal impairment; uses include chronic stable and variant angina, A fib, A flutter, PSVT, and unstable angina; ADRS: syncope, decreased BP, decreased HR, heart block, asystole, CYP-3A4 inhibitor |
|
Definition
|
|
Term
| not preferred due to tolerance issues; vasodilation of coronary arteries (increased oxygen supply); |
|
Definition
|
|
Term
| inhibits cardiac later stage sodium channels, only approved for chronic angina |
|
Definition
|
|
Term
| ADRs include HA, dizziness, N/V, constipation, angioedema, dyspnea, confusion, QTc prolongation, CYP3A4 inhibitor, avoid in hepatic impairment |
|
Definition
|
|
Term
| 40% restenosis within 1 year |
|
Definition
|
|
Term
| 30% restenosis within 1 year |
|
Definition
|
|
Term
| less restenosis (<10%) but see late stenosis when anti-platelet therapy is discontinued (60-70%) |
|
Definition
| Drug eluding stents (DES) |
|
|
Term
| DO NOT USE in Prinzmetal Angina |
|
Definition
|
|
Term
| preferred over nitrates in Prinzmetal Angina |
|
Definition
|
|
Term
| add to calcium channel blockers in Prinzmetal Angina |
|
Definition
|
|
